Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert V House

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|June 28, 2005
Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infectionJeffry D Shearer, Linda Siemann, Mary Gerkovich, et al.
Advances in Preventive Medicine|October 27, 2011
Advanced Development of the rF1V and rBV A/B Vaccines: Progress and ChallengesMary Kate Hart, George A Saviolakis, Susan L Welkos, et al.
International Journal of Toxicology|August 3, 2013
Preclinical safety assessment of a recombinant plague vaccine (rF1V)Jessica L Price, T Scott Manetz, Jeffry D Shearer, et al.
Plos One|April 7, 2010
Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS)Susan M Twine, Mireille D Petit, Kelly M Fulton, et al.
Vaccine|May 30, 2008
Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primatesDonald L Fine, Brian A Roberts, Sara J Terpening, et al.
International Journal of Toxicology|January 18, 2013
Workshop proceedings: challenges and opportunities in evaluating protein allergenicity across biotechnology industriesNicola J Stagg, Hanan N Ghantous, Gregory S Ladics, et al.
European Journal of Immunology|March 29, 2011
Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensisKjell Eneslätt, Cecilia Rietz, Patrik Rydén, et al.
Vaccine|March 1, 2008
An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routesMarcela F Pasetti, Lilian Cuberos, Thomas L Horn, et al.
Vaccine|December 19, 2009
Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunizationJ Wayne Conlan, Hua Shen, Igor Golovliov, et al.
Clinical and Vaccine Immunology : CVI|July 28, 2010
Inhalational botulism in rhesus macaques exposed to botulinum neurotoxin complex serotypes A1 and B1Daniel C Sanford, Roy E Barnewall, Michelle L Vassar, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|June 28, 2005
Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infectionJeffry D Shearer, Linda Siemann, Mary Gerkovich, et al.
Advances in Preventive Medicine|October 27, 2011
Advanced Development of the rF1V and rBV A/B Vaccines: Progress and ChallengesMary Kate Hart, George A Saviolakis, Susan L Welkos, et al.
International Journal of Toxicology|August 3, 2013
Preclinical safety assessment of a recombinant plague vaccine (rF1V)Jessica L Price, T Scott Manetz, Jeffry D Shearer, et al.
Plos One|April 7, 2010
Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS)Susan M Twine, Mireille D Petit, Kelly M Fulton, et al.
Vaccine|May 30, 2008
Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primatesDonald L Fine, Brian A Roberts, Sara J Terpening, et al.
International Journal of Toxicology|January 18, 2013
Workshop proceedings: challenges and opportunities in evaluating protein allergenicity across biotechnology industriesNicola J Stagg, Hanan N Ghantous, Gregory S Ladics, et al.
European Journal of Immunology|March 29, 2011
Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensisKjell Eneslätt, Cecilia Rietz, Patrik Rydén, et al.
Vaccine|March 1, 2008
An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routesMarcela F Pasetti, Lilian Cuberos, Thomas L Horn, et al.
Vaccine|December 19, 2009
Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunizationJ Wayne Conlan, Hua Shen, Igor Golovliov, et al.
Clinical and Vaccine Immunology : CVI|July 28, 2010
Inhalational botulism in rhesus macaques exposed to botulinum neurotoxin complex serotypes A1 and B1Daniel C Sanford, Roy E Barnewall, Michelle L Vassar, et al.
Pageof 3